5/6
08:13 am
amrn
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference [Yahoo! Finance]
Medium
Report
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference [Yahoo! Finance]
5/6
08:00 am
amrn
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Medium
Report
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
5/3
10:59 am
amrn
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
5/3
10:28 am
amrn
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/1
02:25 pm
amrn
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Low
Report
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
5/1
11:04 am
amrn
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/1
07:12 am
amrn
Amarin Reports First Quarter 2024 Business Update and Financial Results [Yahoo! Finance]
Medium
Report
Amarin Reports First Quarter 2024 Business Update and Financial Results [Yahoo! Finance]
5/1
07:00 am
amrn
Amarin Reports First Quarter 2024 Business Update and Financial Results
Medium
Report
Amarin Reports First Quarter 2024 Business Update and Financial Results
4/24
02:13 pm
amrn
Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event [Yahoo! Finance]
Low
Report
Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event [Yahoo! Finance]
4/24
02:00 pm
amrn
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
Low
Report
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
4/22
08:13 am
amrn
Amarin Announces Results of Annual General Meeting of Shareholders [Yahoo! Finance]
Low
Report
Amarin Announces Results of Annual General Meeting of Shareholders [Yahoo! Finance]
4/22
08:00 am
amrn
Amarin Announces Results of Annual General Meeting of Shareholders
Medium
Report
Amarin Announces Results of Annual General Meeting of Shareholders
4/15
08:00 am
amrn
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Medium
Report
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
4/15
07:27 am
amrn
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim [Yahoo! Finance]
Medium
Report
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim [Yahoo! Finance]
4/8
08:00 am
amrn
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
Neutral
Report
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
4/6
03:34 pm
amrn
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups [Yahoo! Finance]
Medium
Report
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups [Yahoo! Finance]
4/6
03:30 pm
amrn
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
Medium
Report
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
4/4
02:43 pm
amrn
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe [Yahoo! Finance]
Medium
Report
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe [Yahoo! Finance]
4/3
08:24 am
amrn
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe [Yahoo! Finance]
Medium
Report
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe [Yahoo! Finance]
4/3
08:00 am
amrn
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
Medium
Report
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
3/25
08:06 am
amrn
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo [Yahoo! Finance]
Low
Report
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo [Yahoo! Finance]
3/25
08:00 am
amrn
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Low
Report
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
3/1
11:10 am
amrn
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Low
Report
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
3/1
08:58 am
amrn
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
03:40 pm
amrn
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]